Actos Heart Problems Not Reported to FDA: Whistleblower Lawsuit
While concerns grew among consumers and the medical community over the risk of heart problems from Avandia, Takeda Pharmaceuticals was allegedly hiding evidence that their competing diabetes drug,...
View ArticleGilenya Safety Concerns Rise as Market Share Drops
Fewer and fewer doctors are prescribing the multiple sclerosis drug Gilenya in the wake of nearly a dozen deaths and safety investigations in the United States, Europe and Canada. Novartis logged a...
View ArticleThoratec HeartMate II LVAS Recall Issued After Bleeding Problems, Death
Problems with the Thoratec HeartMate II Left Ventricular Assist System, which may have caused the death of at least one patient, has led to a recall for all models. The Thoratec Heartmate II recall...
View ArticleMerck Drops New Heart Drug Following Multaq Problems
Concerns over potential side effects similar to those encountered with the Sanofi-Aventis heart drug Multaq may have contributed to Merck & Co.’s decision to drop development of a similar heart...
View ArticleGilenya Problems Lead to Call for Restriction on Use
An organization of drug safety experts is questioning whether the multiple sclerosis (MS) drug Gilenya should be restricted due to increasing concerns over serious and sometimes fatal side effects....
View ArticleGilenya Heart Side Effects Lead To Stronger Warnings
U.S. and European regulators are placing stronger warnings on the multiple sclerosis drug Gilenya, calling for electrocardiogram (ECG) examinations for patients taking the drug due to the potential...
View ArticleGilenya Warning Updated By FDA Over Heart Risks
Federal health officials have updated the warnings for Gilenya, a multiple sclerosis (MS) drug manufactured by Novartis, to indicate that it should not be used by individuals who have recently suffered...
View ArticleGeneric Actos Approved Amid Lawsuits Over Bladder Cancer Warnings
Despite growing concerns about the adequacy of warnings about the risk of bladder cancer from Actos side effects, the FDA approved the first generic version of the popular diabetes drug last week....
View ArticleMirapex Side Effects Could Increase Risk of Heart Failure, FDA Warns
Federal drug regulators are warning that side effects of Mirapex, a Parkinson’s disease and restless leg syndrome drug, may increase the risk of heart failure. The FDA issued a drug safety...
View ArticleAranesp Fails to Help Heart Failure Patients in Clinical Trial
The anemia drug Aranesp, known generically as darbepoetin alfa, failed in clinical trials to treat heart failure and led to some participants experiencing serious adverse side effects, according to...
View ArticleActos Removed from Market in India Amid Bladder Cancer Risk
Following mounting concerns worldwide over the risk of heart failure and bladder cancer from Actos, India became the latest country to ban the popular diabetes drug last month. The Indian Ministry of...
View ArticleKentucky Children’s Hospital Halts Heart Surgeries After Infant Deaths
Infant heart surgery at Kentucky Children’s Hospital has been suspended following the death of two infants and botched heart surgeries that led to severe injuries for at least two others. According...
View ArticleNo Heart Benefits Or Risks Found in Onglyza or Nesina Diabetes Drugs
New research suggests that side effects of Onglyza and Nesina may not actually be harmful to the heart, as once suspected, but also suggest that the diabetes drugs do not appear to be helpful in...
View ArticleDigoxin May Increase Death Risk For Heart Failure Patients: Study
Patients suffering from heart failure may face a higher risk of death when they take the heart drug digoxin, according to the findings of new research. In a study published this month in the medical...
View ArticleCrestor Lawsuit
Side effects of Crestor, a blockbuster cholesterol drug that has been used by millions of people, may be linked to an increased risk of diabetes, heart problems and severe muscle injury. As a result of...
View ArticleSt. Jude Amplatzer ASO Tissue Erosion Problems Result in FDA Warning
Government health officials have issued a warning about a risk of serious problems with a St. Jude cardiac implant instrument, which may create erosion around the heart, posing a risk of severe and...
View ArticleHerceptin Side Effects May Increase Heart Disease In Older Women: Study
New research has linked side effects of Herceptin, a popular breast cancer treatment drug, to higher incidents of heart problems among older women. In a study published in the Journal of Clinical...
View ArticleOnglyza Lawsuit
Side effects of Onglyza, a popular diabetes drug, may increase the risk of serious and potentially life-threatening injuries, including pancreatic cancer and heart failure. ONGLYZA LAWSUIT STATUS:...
View ArticleFDA Panel Addresses Painkiller Cardiac Safety Labels This Week
A panel of drug experts is expected to weigh in on whether painkiller drugs like Advil, Aleve and Celebrex may pose a greater cardiac risk. A joint meeting of the FDA’s Arthritis Advisory Committee and...
View ArticleOnglyza Heart Risks to be Reviewed by FDA
Federal drug regulators are concerned that the diabetes drug Onglyza may carry serious heart risks, after a study that found an increased rate of heart failure among users. On February 11, the FDA...
View Article
